Mounjaro® (Tirzepatide) Injection 12.5 mg/0.5 mL – Prefilled Syringes (4-Pack, RX Only)

Description

Mounjaro® (Tirzepatide) Injection 12.5 mg/0.5 mL – Prefilled Syringes (4-Pack, RX Only). By activating these natural hormone pathways, Mounjaro increases insulin release when blood sugar levels are elevated, reduces the release of glucagon (a hormone that raises blood sugar), and slows the rate at which food leaves the stomach. These combined effects help improve blood sugar control throughout the week and often support appetite reduction and weight loss in patients with type 2 diabetes.

The 12.5 mg dose is typically prescribed for patients who have already adjusted to lower doses and require stronger glycemic support. Each carton includes four single-use, prefilled syringes, with one injection administered per week. The medication is injected just under the skin and is designed for convenient at-home use when prescribed by a healthcare provider.

Mounjaro is not insulin and is not used to treat type 1 diabetes. It should be used alongside a balanced diet, regular physical activity, and ongoing medical supervision for optimal results.

How Mounjaro Is Used

Mounjaro is injected once weekly, on the same day each week, into the abdomen, thigh, or upper arm. Injection sites should be rotated to reduce skin irritation. Before use, the syringe should be inspected to ensure the solution is clear and that the medication has not expired.

After cleaning the injection site with an alcohol swab, the syringe is administered subcutaneously as directed by your healthcare provider. Each syringe is intended for single use only and should be disposed of in an approved sharps container after injection.

If a dose is missed, it may be taken as soon as remembered, provided the next scheduled dose is at least three days away. Patients should never take two doses within the same week unless instructed by a healthcare professional.

Unused Mounjaro syringes must be stored in the refrigerator and should never be frozen. Always follow storage and handling instructions provided with the medication.

Important Medical Information

Mounjaro is available by prescription only and should be used exactly as prescribed by a licensed healthcare provider. Blood sugar levels should be monitored regularly, and any side effects or concerns should be discussed with a medical professional. Your provider will determine whether tirzepatide is appropriate for your diabetes management or medical weight loss goals.

---

What Makes Mounjaro Different?

Unlike traditional GLP-1 medications, Mounjaro targets both GLP-1 and GIP receptors. These two hormones work together to regulate insulin secretion, appetite, and glucose metabolism. By activating both pathways, tirzepatide can improve insulin sensitivity and blood sugar control more comprehensively, which is why it has become a leading option in modern diabetes care and physician-guided weight management programs.